• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境风险因素与家族性扩张型心肌病的自然病史相关。

Environmental Risk Factors Are Associated With the Natural History of Familial Dilated Cardiomyopathy.

作者信息

Peters Stacey A, Wright Leah, Yao Jess, McCall Lauren, Thompson Tina, Thompson Bryony, Johnson Renee, Huynh Quan, Santiago Celine F, Trainer Alison, Perrin Mark, James Paul, Zentner Dominica, Kalman Jon, Marwick Thomas H, Fatkin Diane

机构信息

Department of Cardiology Royal Melbourne Hospital Melbourne Victoria Australia.

Department of Genomic Medicine Royal Melbourne Hospital Melbourne Victoria Australia.

出版信息

J Am Heart Assoc. 2025 May 6;14(9):e037311. doi: 10.1161/JAHA.124.037311. Epub 2025 May 2.

DOI:10.1161/JAHA.124.037311
PMID:40314344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12184215/
Abstract

BACKGROUND

Familial dilated cardiomyopathy (DCM) is characterized by marked variability in phenotypic penetrance. The extent to which this is determined by patient-specific environmental factors is unknown.

METHODS AND RESULTS

A retrospective longitudinal cohort study was performed in families with DCM-causing genetic variants. Environmental factors were classified into 2 subsets based on evidence for a causal link to depressed myocardial contractility, termed (1) DCM-promoting factors and (2) heart failure comorbidities. These factors were correlated with DCM diagnosis and disease trajectory after accounting for relevant confounders and familial relatedness. A total of 105 probands and family members were recruited: 51 genotype positive, phenotype positive, 24 genotype positive, phenotype negative, and 30 genotype negative, phenotype negative. Demographic characteristics were similar between the 3 genotype groups. DCM-promoting environmental factors (eg, alcohol excess) were enriched in genotype-positive, phenotype-positive individuals compared with genotype-positive, phenotype-negative (<0.001) and genotype-negative, phenotype-negative (=0.003) individuals and were significantly associated with age at DCM onset (hazard ratio, 2.01; =0.014). Heart failure comorbidities (eg, diabetes) had a similar prevalence in genotype-positive, phenotype-positive and genotype-negative, phenotype-negative individuals but were significantly reduced in the genotype-positive, phenotype-negative group. Fluctuations in left ventricular ejection fraction during follow-up were linked to changes in environmental factors in 35 of 45 (78%) of instances: 32 (91%) of these were DCM-promoting factors.

CONCLUSIONS

We identified distinct subsets of environmental factors that affect DCM penetrance and trajectory. Our data highlight DCM-promoting environmental factors as key determinants of penetrance and natural history. Collectively, these findings provide a new framework for risk factor assessment in familial DCM and have important implications for clinical management.

摘要

背景

家族性扩张型心肌病(DCM)的特征是表型外显率存在显著差异。而这在多大程度上由患者特异性环境因素决定尚不清楚。

方法与结果

对携带导致DCM的基因变异的家族进行了一项回顾性纵向队列研究。根据与心肌收缩力降低存在因果关系的证据,将环境因素分为2个亚组,即(1)促DCM因素和(2)心力衰竭合并症。在考虑了相关混杂因素和家族相关性后,将这些因素与DCM诊断及疾病轨迹进行关联分析。共招募了105名先证者及其家庭成员:51名基因型阳性、表型阳性,24名基因型阳性、表型阴性,以及30名基因型阴性、表型阴性。3个基因型组之间的人口统计学特征相似。与基因型阳性、表型阴性个体(<0.001)和基因型阴性、表型阴性个体(=0.003)相比,促DCM环境因素(如过量饮酒)在基因型阳性、表型阳性个体中更为常见,且与DCM发病年龄显著相关(风险比,2.01;=0.014)。心力衰竭合并症(如糖尿病)在基因型阳性、表型阳性个体和基因型阴性、表型阴性个体中的患病率相似,但在基因型阳性、表型阴性组中显著降低。随访期间左心室射血分数的波动在45例中的35例(78%)与环境因素变化有关:其中32例(91%)为促DCM因素。

结论

我们识别出了影响DCM外显率和疾病轨迹的不同环境因素亚组。我们的数据突出了促DCM环境因素是外显率和自然病史的关键决定因素。总体而言,这些发现为家族性DCM的危险因素评估提供了一个新框架,并对临床管理具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/190ae049ab7f/JAH3-14-e037311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/c4bafda27674/JAH3-14-e037311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/04e3ded1fa4e/JAH3-14-e037311-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/2ace4e1b557b/JAH3-14-e037311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/00a863e0774c/JAH3-14-e037311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/190ae049ab7f/JAH3-14-e037311-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/c4bafda27674/JAH3-14-e037311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/04e3ded1fa4e/JAH3-14-e037311-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/2ace4e1b557b/JAH3-14-e037311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/00a863e0774c/JAH3-14-e037311-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a17/12184215/190ae049ab7f/JAH3-14-e037311-g004.jpg

相似文献

1
Environmental Risk Factors Are Associated With the Natural History of Familial Dilated Cardiomyopathy.环境风险因素与家族性扩张型心肌病的自然病史相关。
J Am Heart Assoc. 2025 May 6;14(9):e037311. doi: 10.1161/JAHA.124.037311. Epub 2025 May 2.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
[Genetic analysis of six adult patients with Dilated cardiomyopathy and analysis of structural variants].[6例扩张型心肌病成年患者的基因分析及结构变异分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025 Apr 10;42(4):433-440. doi: 10.3760/cma.j.cn511374-20241001-00518.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

引用本文的文献

1
Discovery of as a New Gene Predisposing to Dilated Cardiomyopathy.发现一个导致扩张型心肌病的新易感基因。
Diagnostics (Basel). 2025 Aug 13;15(16):2031. doi: 10.3390/diagnostics15162031.

本文引用的文献

1
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.全球可改变风险因素对心血管疾病和死亡的影响。
N Engl J Med. 2023 Oct 5;389(14):1273-1285. doi: 10.1056/NEJMoa2206916. Epub 2023 Aug 26.
2
Cardiac Inflammation in Adult-Onset Genetic Dilated Cardiomyopathy.成人起病型遗传性扩张型心肌病中的心脏炎症
J Clin Med. 2023 Jun 9;12(12):3937. doi: 10.3390/jcm12123937.
3
Pregnancy Outcomes in Females With Dilated Cardiomyopathy-Associated Rare Genetic Variants.患有扩张型心肌病相关罕见基因变异女性的妊娠结局
Circ Genom Precis Med. 2022 Apr;15(2):e003540. doi: 10.1161/CIRCGEN.121.003540. Epub 2022 Feb 3.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.2021 ESC 急性和慢性心力衰竭诊断和治疗指南:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断和治疗工作组制定。特别感谢欧洲心脏病学会心力衰竭协会(HFA)的贡献。
Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333.
5
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.非缺血性扩张型心肌病患者基因变异与预后的关联
J Am Coll Cardiol. 2021 Oct 26;78(17):1682-1699. doi: 10.1016/j.jacc.2021.08.039.
6
The Complex and Diverse Genetic Architecture of Dilated Cardiomyopathy.扩张型心肌病的复杂多样的遗传结构。
Circ Res. 2021 May 14;128(10):1514-1532. doi: 10.1161/CIRCRESAHA.121.318157. Epub 2021 May 13.
7
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.基于证据的扩张型心肌病相关基因评估。
Circulation. 2021 Jul 6;144(1):7-19. doi: 10.1161/CIRCULATIONAHA.120.053033. Epub 2021 May 5.
8
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the Gene.基因突变导致扩张型心肌病的临床表型和预后。
Circ Heart Fail. 2020 Oct;13(10):e006832. doi: 10.1161/CIRCHEARTFAILURE.119.006832. Epub 2020 Sep 23.
9
Precision Medicine in the Management of Dilated Cardiomyopathy: JACC State-of-the-Art Review.精准医疗在扩张型心肌病管理中的应用:美国心脏病学会的最新综述。
J Am Coll Cardiol. 2019 Dec 10;74(23):2921-2938. doi: 10.1016/j.jacc.2019.10.011.
10
Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants.基于基因组优先的策略评估与截断性肌联蛋白变异相关的心脏病。
Circulation. 2019 Jul 2;140(1):42-54. doi: 10.1161/CIRCULATIONAHA.119.039573. Epub 2019 Jun 20.